Author:
Parthan Anju,Leahy Kevin J.,O’Sullivan Amy K.,Iakoubova Olga A.,Bare Lance A.,Devlin James J.,Weinstein Milton C.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference29 articles.
1. Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–209.
2. Schwartz GG, Olsson AG, Ezekowitz MD, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711–8.
3. Heart Disease and Stroke Statistics, 2009 update at a glance. Dallas: American Heart Association; 2009.
4. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15(2 Suppl):S36–41.
5. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献